Drug profile · INN
ipragliflozin l-proline
SUGLAT INITIAL APPROVAL
- Patents linked
- 0
- News articles
- 0
Quick answer
ipragliflozin l-proline (SUGLAT INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN ipragliflozin l-proline
Brand SUGLAT INITIAL APPROVAL
Frequently asked questions
What is ipragliflozin l-proline?
ipragliflozin l-proline (SUGLAT INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for ipragliflozin l-proline?
SUGLAT INITIAL APPROVAL is a marketed brand name for ipragliflozin l-proline. Check FDA Drugs@FDA for the current US label holder and prescribing information.